Fibrosis Patients Who used Pulmozyme Experienced A Slower Rate Of Lung Function Decline And An Immediate Improvement In Lung Function

... Data presented this past Friday at the North America Cystic Fibrosis Conference (NACFC) in Denver showed that cystic fibrosis patients who used Pulmozyme experienced a slower rate of lung function decline and an immediate improvement in lung function, as compared to cystic fibrosis patients not treated with Pulmozyme. [click link for full article] ...